What an FDA Inspector Can Ask You for in the First 5 Minutes
DSCSA readiness is tested fastest when someone asks for proof before your pharmacy has time to get organized.
No pharmacy wants to be surprised by an inspector. But the real problem is not simply the visit. It is being asked a basic DSCSA question and realizing the answer is spread across emails, supplier portals, downloads, spreadsheets, and one person’s memory.
Your pharmacy should be ready to show that it knows its suppliers, receives and retains transaction records, can retrieve information when needed, and has procedures for suspect or illegitimate product concerns.
A simple question can expose a complicated process.
The issue is not whether the record might exist somewhere. The issue is whether trained staff know where it is and can show it.
An FDA inspector may not ask every question in exactly the same way. But a pharmacy should be able to identify its suppliers, show transaction records, retrieve information tied to a shipment, describe what happens when data is missing, explain suspect-product procedures, and demonstrate a reliable retention process.
That is the difference between preparation and panic.
Know the supplier. Find the record. Explain the process.
Those three capabilities sit underneath many of the questions a pharmacy may need to answer quickly.
Know your suppliers
Identify active suppliers, associated accounts and locations, keep information current, and support Authorized Trading Partner review.
Find transaction records
Know where EPCIS, EDI 856, ASN, supplier-portal, and related transaction documentation are stored and how to retrieve them.
Explain what happened
Be able to show missing-data follow-up, exceptions, reconciliation, suspect-product activity, and how records are retained.
What could the first five minutes sound like?
Practice these questions with real suppliers, real shipments, real records, and the staff who would actually need to respond.
“Who are your suppliers?”
This may sound basic. It is not. Your pharmacy should be able to identify active suppliers and support that prescription drug product is being purchased from Authorized Trading Partners.
- Which suppliers are active?
- Which locations or accounts are connected to each supplier?
- Is supplier information current?
- How are new suppliers or accounts added?
- Who keeps the supplier list updated?
If the pharmacy cannot quickly explain who supplies prescription drug product, the rest of the DSCSA process becomes harder to defend.
“Where is your transaction data?”
The pharmacy should know where DSCSA transaction records are stored and how to retrieve them.
- EPCIS records
- EDI 856 records
- ASN records
- Supplier-portal records
- Other transaction documentation
- Related missing-data or exception records
Risky answer: “We think it is somewhere.”
Stronger answer: “Here is where the record is, here is the supplier, here is the shipment, and here is what happened.”
“Can you show records for this shipment?”
An inspector may ask about a specific shipment, product, supplier, date, or transaction. Your pharmacy should be able to connect the pieces.
- Supplier
- Shipment
- Product
- Transaction data
- Lot or product identifier information where available
- Receipt or reconciliation activity
- Missing-data notes, if applicable
- Exception documentation, if applicable
If staff must search several systems, call one person, or rebuild the story manually, the pharmacy may look less prepared than it is.
“What do you do when transaction data is missing?”
Missing data happens. The key question is whether the pharmacy has a process and can document what it did.
- How are missing or delayed records identified?
- Who reviews the issue?
- Who contacts the supplier?
- Where is follow-up documented?
- When is the issue escalated?
- How does the pharmacy show what it did?
A missing-data issue handled through a documented workflow is stronger than one handled by memory.
“How do you handle suspect product?”
Pharmacies should have procedures for identifying, investigating, quarantining when appropriate, documenting, escalating, and reporting suspect or illegitimate product concerns.
- How do staff recognize a concern?
- When is product quarantined?
- Who investigates?
- What records are reviewed?
- How is supplier or manufacturer follow-up documented?
- When might reporting be required?
- How is resolution documented?
The middle of an inspection is the wrong time to discover that staff are unsure who to call or what to do.
“Can more than one person retrieve the records?”
DSCSA readiness should not depend on a single employee. People get busy, take vacation, change roles, or leave.
More than one trained person should know where records are stored, how to retrieve them, and what to do when information is missing or questionable.
If only one person can answer DSCSA questions, the process is too fragile.
“How long do you retain DSCSA records?”
Pharmacies should have a process for record retention and retrieval over the required retention period.
- Where are records retained?
- Who can access them?
- How are records organized?
- How are records tied to suppliers, shipments, products, and dates?
- How can records be retrieved later?
Retention is not just saving data. Retention means being able to find and explain it later.
A slow answer is not automatically a violation—but it creates risk.
Slow, unclear, or incomplete answers can make a pharmacy look less prepared, create unnecessary pressure, and expose problems that could have been addressed earlier.
The article notes that DSCSA should be treated seriously. In serious cases, violations tied to prohibited acts under the Federal Food, Drug, and Cosmetic Act can create civil or criminal exposure. That does not mean every documentation issue becomes a criminal case.
Run the first-five-minutes test yourself.
Pick one real shipment and see whether your team can work through the information without rebuilding the story.
Pick a recent shipment.
Identify the supplier.
Retrieve the transaction data.
Check whether anything was missing or delayed.
Review reconciliation or exception documentation.
Ask someone other than the usual person to find the record.
If that process feels difficult now, it will feel worse under inspection pressure.
Prepare before anyone asks the first question.
Advasur 360 helps pharmacies organize DSCSA activity so teams can move from “Let me see if we can find that” to “Here is the record. Here is what happened.”
Transaction data receipt and retention
Support for receiving, retaining, organizing, and retrieving DSCSA transaction information.
EPCIS and EDI 856 record management
Keep electronic records connected to supplier, shipment, and pharmacy workflows.
Supplier and shipment visibility
Help organize supplier relationships, accounts, locations, shipment activity, and associated records.
Authorized Trading Partner support
Support for supplier information, review, and documentation as part of a practical workflow.
Reconciliation activity
Support review and comparison of received product with shipment or transaction information.
Missing-data workflows
Identify, document, follow up on, resolve, or escalate missing and delayed information.
Exception documentation
Maintain the issue, review, follow-up, resolution, escalation, and supporting record.
Suspect-product procedures
Support identification, quarantine, investigation, documentation, escalation, and reporting when appropriate.
Staff training support
Practical support so more than one trained person understands how the pharmacy's DSCSA workflow works.
Six-year record retention
Help keep long-term records organized, accessible, and explainable over time.
Record retrieval
Help staff produce records when someone asks instead of rebuilding the story manually.
Built by pharmacists, for pharmacists: Advasur 360 was shaped by more than a decade of focused DSCSA experience and includes white-glove support from people who understand pharmacy operations.
The first five minutes should not feel like a scavenger hunt.
If your pharmacy is not confident it could answer DSCSA questions in the first five minutes of an inspection, now is the time to get ready.
In a 30-minute Advasur 360 DSCSA Readiness Review, we can walk through your current process and help identify what needs attention before the November 27, 2027 deadline.
We can review:
- ✓ Supplier setup
- ✓ Transaction data receipt and retention
- ✓ EPCIS and EDI 856 readiness
- ✓ Missing-data workflows
- ✓ Reconciliation activity
- ✓ Exception documentation
- ✓ Suspect-product procedures
- ✓ Staff training
- ✓ Six-year record retention
- ✓ Record retrieval
No pressure. No scare tactics. Just a practical look at whether your pharmacy can show what happened when someone asks.